Evidence map›Paper›PMID 26692026›Full record

ArticlePloS one2015

Combinatorial Screening for Transgenic Yeasts with High Cellulase Activities in Combination with a Tunable Expression System.

Yoichiro Ito, Mamoru Yamanishi, Akinori Ikeuchi, Chie Imamura, Takashi Matsuyama

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yoichiro ItoMatsuyama Research Group, TOYOTA Central Research and Development Laboratories Incorporation, Nagakute, Aichi, Japan.
Mamoru YamanishiMatsuyama Research Group, TOYOTA Central Research and Development Laboratories Incorporation, Nagakute, Aichi, Japan.
Akinori IkeuchiBiotechnology Laboratory, TOYOTA Central Research and Development Laboratories Incorporation, Nagakute, Aichi, Japan.
Chie ImamuraBiotechnology Laboratory, TOYOTA Central Research and Development Laboratories Incorporation, Nagakute, Aichi, Japan.
Takashi MatsuyamaMatsuyama Research Group, TOYOTA Central Research and Development Laboratories Incorporation, Nagakute, Aichi, Japan.
Toyota Central Research and Development Laboratories (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Combinatorial screening used together with a broad library of gene expression cassettes is expected to produce a powerful tool for the optimization of the simultaneous expression of multiple enzymes. Recently, we proposed a highly tunable protein expression system that utilized multiple genome-integrated target genes to fine-tune enzyme expression in yeast cells. This tunable system included a library of expression cassettes each composed of three gene-expression control elements that in different combinations produced a wide range of protein expression levels. In this study, four gene expression cassettes with graded protein expression levels were applied to the expression of three cellulases: cellobiohydrolase 1, cellobiohydrolase 2, and endoglucanase 2. After combinatorial screening for transgenic yeasts simultaneously secreting these three cellulases, we obtained strains with higher cellulase expressions than a strain harboring three cellulase-expression constructs within one high-performance gene expression cassette. These results show that our method will be of broad use throughout the field of metabolic engineering.

Indexed as

Gene ExpressionCellulaseEscherichia coliFungal ProteinsPhanerochaeteRecombinant ProteinsSaccharomyces cerevisiaeTalaromycesCellulaseFungal ProteinsRecombinant Proteins

Identifiers

PMID26692026
PMCPMC4687128
OpenAlexW2414280252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.